XML 80 R47.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share capital - Narrative (Details)
12 Months Ended
Apr. 30, 2012
shares
Nov. 30, 2021
USD ($)
$ / shares
shares
Nov. 30, 2021
USD ($)
$ / shares
$ / shares
shares
Nov. 30, 2020
USD ($)
$ / shares
shares
Nov. 30, 2020
USD ($)
$ / shares
shares
Nov. 30, 2019
USD ($)
$ / shares
shares
Nov. 30, 2019
USD ($)
$ / shares
shares
Nov. 30, 2021
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock-based compensation | $   $ (3,472,000)   $ (3,564,000)   $ (3,845,000)    
Non-vested stock options outstanding   10,539,324 10,539,324          
Weighted average exercise price options outstanding | $ / shares               $ 1.99
Stock option expense not yet recognized | $   $ 500,000 $ 500,000          
Period for recognition of stock compensation expense   2 years            
Aggregate intrinsic value, vested options | $   $ 800,000 800,000 2,400,000 $ 2,400,000 7,200,000 $ 7,200,000  
Aggregate intrinsic value, options exercised | $   $ 1,400,000   $ 2,600,000   2,600,000    
Rolling maximum number, percentage of the issued and outstanding Common Shares   10.00%            
Warrants outstanding | $   $ 0 $ 0          
Exercise of warrants | $           $ 9,900,000    
Exercise of warrants (Shares)           6,521,740    
Maximum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting period   5 years            
Minimum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Rolling maximum number, percentage of the issued and outstanding Common Shares   10.00%            
Share capital                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Common stock committed for issuance   145,009,811 145,009,811 144,137,850 144,137,850 140,427,761 140,427,761  
Exercise of warrants (Shares)           6,521,740    
Nonvested Options                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Non-vested stock options outstanding   2,526,338 2,526,338          
Weighted average exercise price options outstanding | $ / shares   $ 2.06 $ 2.06          
Restricted Share Units and Deferred Share Units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of shares, conversion   1            
DSUs                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Common stock committed for issuance   11,927 11,927          
Granted units   58,925   83,775   137,514    
Outstanding grants   1,277,445 1,277,445 1,218,520 1,218,520      
Annual retainer percentage in DSUs   50.00%            
RSUs                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Granted units   0            
NovaGold Arrangement                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of shares, conversion 6              
Common stock, terms of conversion On April 30, 2012, under the NovaGold Arrangement, Trilogy committed to issue common shares to satisfy holders of NovaGold deferred share units (“NovaGold DSUs”), once vested, on record as of the close of business April 27, 2012. When vested, Trilogy committed to deliver one common share to the holder for every six shares of NovaGold the holder is entitled to receive, rounded down to the nearest whole number.              
Common Stock, Other Shares, Outstanding   1,988 1,988          
Stock Compensation Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock-based compensation | $   $ 100,000   $ 500,000   $ 900,000    
Stock Option.                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock-based compensation | $   $ 3,300,000   $ 3,100,000   $ 2,900,000    
Closing foreign exchange rate   0.7817 0.7817          
Employees, consultants and directors                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock options granted   3,374,150   4,445,000   3,077,500    
Weighted-average exercise price | $ / shares     $ 2.52   $ 2.79   $ 2.86  
Stock options granted, weighted average fair value | $ / shares   $ 0.84   $ 0.90   $ 1.03    
Employees, consultants and directors | Maximum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting period   5 years            
Employees, consultants and directors | Minimum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting period   2 years